“…Comparatively, human neutrophil elastase has been targeted with oleic acid/albumin formulations. 54,55 Another example of a dressing type that acts to control the microenvironment of the wound incorporates a healing accelerator, nanooligosaccharide factor, which has antiprotease properties and is released from the dressing upon contact with chronic wound fluid; this type of dressing aims to sequester the protease activity within the nonhealing wound. 56 Alternatively, Adhirajan et al 57 demonstrated the potential of modified gelatin microspheres with a catechol MMP inhibitor combined with antimicrobials incorporated into a collagen scaffold to combine the benefits of infection control and attenuation of proteases in diabetic wound tissue lysates.…”